Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Apr 15, 2021 3:12pm
102 Views
Post# 33004610

RE:RE:RE:RE:RE:RE:RE:Its always the "next" new release.

RE:RE:RE:RE:RE:RE:RE:Its always the "next" new release. Exacttly.  It's like free funding with no dillution.  $5 million so far with more quarters to come.  Makes no sense that its still valued down here wait until q1 on May 17 and we see another $4-5 million maybe people will wake up.

capebretongirl wrote:
Northerencents wrote: In one sense I would agree, covid revenue can't be considered sustainable...on the other hand it very well could be a much longer term thing it will be tested for, for a very long time 



Can you imagine what things would look like if the Richmond lab was not converted for covid testing and thus no revenue over the past year and the year to come.  The bashers would have ammunition and some credibility as all we would have is that $473,000. Fact is though that we have seen massive dollars and Qs1,2,3 will be unprecented.  Doesn't matter if anyone calls it unsustainable because its real and right now - the bashers just don't like it because they know the inevitable outcome will be a positive one.


<< Previous
Bullboard Posts
Next >>